Document Type
Article
Publication Date
September 2018
Patent Number
10076534
CPC
A61K 31/7064, A61K 31/7052, A61K 31/7042, A61K 31/706, A61K 31/7056, A61K 31/0019, A61K 9/127, A61K 9/14, A61K 9/20, C07H 19/04, C07H 19/23
Abstract
The inventors have determined, contrary to the prior art and experience, how to successfully use triciribine to treat ovarian cancer by one or a combination of (i) administering triciribine only to patients which according to a diagnostic test described below, exhibit enhanced sensitivity to the drug; (ii) use of a described dosage level that minimizes the toxicity of the drug but yet still exhibits efficacy; or (iii) use of a described dosage regimen that minimizes the toxicity of the drug.
Application Number
15/218728
Recommended Citation
Cheng, Jin Q., "Effective treatment of ovarian cancer using triciribine and related compounds" (2018). USF Patents. 1069.
https://digitalcommons.usf.edu/usf_patents/1069
Assignees
University of South Florida
Filing Date
07/25/2016
